Literature DB >> 21333627

Impairment of neuropsychological behaviors in ganglioside GM3-knockout mice.

Kimie Niimi1, Chieko Nishioka, Tomomi Miyamoto, Eiki Takahashi, Ichiro Miyoshi, Chitoshi Itakura, Tadashi Yamashita.   

Abstract

The ganglioside GM3 synthase (SAT-I), encoded by a single-copy gene, is a primary glycosyltransferase for the synthesis of complex gangliosides. Although its expression is tightly controlled during early embryo development and postnatal development and maturation in the brain, the physiological role of ganglioside GM3 in the regulation of neuronal functions has not been elucidated. In the present study, we examined motor activity, cognitive and emotional behaviors, and drug administration in juvenile GM3-knockout (GM3-KO) mice. GM3-KO male and female mice showed hyperactivity in the motor activity test, Y-maze test, and elevated plus maze test. In the Y-maze test, there was significantly less spontaneous alternation behavior in GM3-KO male mice than in wild-type mice. In the elevated plus maze test, the amount of time spent on the open arms by GM3-KO male mice was significantly higher than that of sex-matched wild-type mice. In contrast, there was no significant difference between GM3-KO and wild-type female mice in these tests. Thus, juvenile GM3-KO mice show gender-specific phenotypes resembling attention-deficit hyperactivity disorder (ADHD), namely hyperactivity, reduced attention, and increased impulsive behaviors. However, administration of methylphenidate hydrochloride (MPH) did not ameliorate hyperactivity in either male or female GM3-KO mice. Although these data demonstrate the involvement of ganglioside GM3 in ADHD and the ineffectiveness of MPH, the first-choice psychostimulant for ADHD medication, our studies indicate that juvenile GM3-KO mice are a useful tool for neuropsychological studies.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21333627     DOI: 10.1016/j.bbrc.2011.02.071

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

Review 1.  Structures, biosynthesis, and functions of gangliosides--an overview.

Authors:  Robert K Yu; Yi-Tzang Tsai; Toshio Ariga; Makoto Yanagisawa
Journal:  J Oleo Sci       Date:  2011       Impact factor: 1.601

2.  A mutation in a ganglioside biosynthetic enzyme, ST3GAL5, results in salt & pepper syndrome, a neurocutaneous disorder with altered glycolipid and glycoprotein glycosylation.

Authors:  Luigi Boccuto; Kazuhiro Aoki; Heather Flanagan-Steet; Chin-Fu Chen; Xiang Fan; Frank Bartel; Marharyta Petukh; Ayla Pittman; Robert Saul; Alka Chaubey; Emil Alexov; Michael Tiemeyer; Richard Steet; Charles E Schwartz
Journal:  Hum Mol Genet       Date:  2013-09-10       Impact factor: 6.150

Review 3.  Human genetic disorders of sphingolipid biosynthesis.

Authors:  Leonardo Astudillo; Frédérique Sabourdy; Nicole Therville; Heiko Bode; Bruno Ségui; Nathalie Andrieu-Abadie; Thorsten Hornemann; Thierry Levade
Journal:  J Inherit Metab Dis       Date:  2014-08-21       Impact factor: 4.982

Review 4.  Functional roles of gangliosides in neurodevelopment: an overview of recent advances.

Authors:  Robert K Yu; Yi-Tzang Tsai; Toshio Ariga
Journal:  Neurochem Res       Date:  2012-03-13       Impact factor: 3.996

5.  Functional Impairment of the Nervous System with Glycolipid Deficiencies.

Authors:  Yutaka Itokazu; Takahiro Fuchigami; Robert K Yu
Journal:  Adv Neurobiol       Date:  2023

6.  Ablation of neuronal ceramide synthase 1 in mice decreases ganglioside levels and expression of myelin-associated glycoprotein in oligodendrocytes.

Authors:  Christina Ginkel; Dieter Hartmann; Katharina vom Dorp; Armin Zlomuzica; Hany Farwanah; Matthias Eckhardt; Roger Sandhoff; Joachim Degen; Mariona Rabionet; Ekrem Dere; Peter Dörmann; Konrad Sandhoff; Klaus Willecke
Journal:  J Biol Chem       Date:  2012-10-16       Impact factor: 5.157

7.  Ganglioside GM3 has an essential role in the pathogenesis and progression of rheumatoid arthritis.

Authors:  Yukinori Tsukuda; Norimasa Iwasaki; Naoki Seito; Masashi Kanayama; Naoki Fujitani; Yasuro Shinohara; Yasuhiko Kasahara; Tomohiro Onodera; Koji Suzuki; Tsuyoshi Asano; Akio Minami; Tadashi Yamashita
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

8.  Stressor-like effects of c-Jun N-terminal kinase (JNK) inhibition.

Authors:  Melanie Clarke; Rowan Pentz; Jessica Bobyn; Shawn Hayley
Journal:  PLoS One       Date:  2012-08-29       Impact factor: 3.240

9.  TALEN mediated targeted editing of GM2/GD2-synthase gene modulates anchorage independent growth by reducing anoikis resistance in mouse tumor cells.

Authors:  Barun Mahata; Avisek Banerjee; Manjari Kundu; Uday Bandyopadhyay; Kaushik Biswas
Journal:  Sci Rep       Date:  2015-03-12       Impact factor: 4.379

10.  Upregulating β-hexosaminidase activity in rodents prevents α-synuclein lipid associations and protects dopaminergic neurons from α-synuclein-mediated neurotoxicity.

Authors:  Oeystein R Brekk; Joanna A Korecka; Cecile C Crapart; Mylene Huebecker; Zachary K MacBain; Sara Ann Rosenthal; Miguel Sena-Esteves; David A Priestman; Frances M Platt; Ole Isacson; Penelope J Hallett
Journal:  Acta Neuropathol Commun       Date:  2020-08-06       Impact factor: 7.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.